|
BRAF/MEK inhibition in melanoma patients with rare BRAF mutations. |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche |
Consulting or Advisory Role - Amgen; Merck Serono; MSD |
Research Funding - 4SC (Inst); Amgen (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Novartis (Inst); Philogen (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - MSD |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
|
|
Honoraria - Bristol-Myers Squibb; Incyte; Merck; Novartis; Roche |
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Incyte; MERCK; Novartis; Pierre Fabre; Roche/Genentech |
|
|
Honoraria - Bristol-Myers Squibb; Merck; Novartis |
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Roche (Inst); TEVA (Inst) |
Speakers' Bureau - GlaxoSmithKline; Merck |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Roche Pharma AG |
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Roche Pharma AG |
|
|
Consulting or Advisory Role - Array Biopharma; Bristol-Myers Squibb; Genoptix; Incyte; Merck; Novartis |
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Incyte |
Patents, Royalties, Other Intellectual Property - Intellectual property and patents pending surrounding use of MHC-II and response to immune therapy |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche Pharma AG |
Travel, Accommodations, Expenses - Amgen; Merck Sharp & Dohme |
|
|
Honoraria - Bristol-Myers Squibb; MSD Oncology; Novartis |
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis |
|
|
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche |
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; Roche |
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche |
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche |
|
|
No Relationships to Disclose |
|
|
Honoraria - GlaxoSmithKline; Merck Serono; MSD; Novartis; Roche |
Consulting or Advisory Role - Novartis; Roche |
Travel, Accommodations, Expenses - GlaxoSmithKline; Merck Serono; MSD; Novartis; Roche |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche |
Research Funding - Novartis |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Novartis; Roche |
|
|
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche |
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Roche Pharma AG |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis |
|
|
Honoraria - Abbvie; Bristol-Myers Squibb; Galderma; LEO Pharma; MSD; Novartis; Pierre Fabre; Roche |
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; LEO Pharma; MSD; Novartis; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; LEO Pharma; Novartis |
|
|
No Relationships to Disclose |
|
|
Honoraria - Biotest; Bristol-Myers Squibb |
Consulting or Advisory Role - MSD |